In exciting news for patients suffering with overactive bladder, the FDA has now recommended approval of a novel medication, mirabegron. Unlike the current overactive bladder medications, this medicine works on a different receptor and mechanism.
While the effects were novel, the panel approved this medication due to its alternative treatment pathway. Not currently on the market, look for arrival in the next year.
To read the study, follow the link http://bit.ly/IJdiES
No comments:
Post a Comment